EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

FABP4+ macrophages promote glycolysis in lung cancer progression through the TNF-α–MYC pathway

Lingwei Liu, Weibin Shu, Chuanxi Wang, Qiang Wen, Hongchang Shen, Qiang Li, Keying Che

Cancer Immunology, Immunotherapy · 18.11.2026

DOI: 10.1007/s00262-026-04646-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 18.11.2026. Verfasst von Lingwei Liu und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Liu, L., Shu, W., Wang, C., Wen, Q., Shen, H., Li, Q., & Che, K. (2026). FABP4+ macrophages promote glycolysis in lung cancer progression through the TNF-α–MYC pathway. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04646-y

Vancouver

Liu L, Shu W, Wang C, Wen Q, Shen H, Li Q, et al. FABP4+ macrophages promote glycolysis in lung cancer progression through the TNF-α–MYC pathway. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04646-y

BibTeX
@article{Liu2026,
  author = {Liu, Lingwei and Shu, Weibin and Wang, Chuanxi and Wen, Qiang and Shen, Hongchang and Li, Qiang and Che, Keying},
  title = {FABP4+ macrophages promote glycolysis in lung cancer progression through the TNF-α–MYC pathway},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  doi = {10.1007/s00262-026-04646-y}
}
Kostenlos starten →